Q4 2021 Holdings
Filed 2022-02-16 | 47 holdings | $86.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $25.6M | 190,000 | 29.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $14.6M | 1,700,000 | 16.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $13.5M | 350,000 | 15.7% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $9.0M | 110,000 | 10.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $5.1M | 30,000 | 5.9% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $4.8M | 200,000 | 5.6% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $4.7M | 325,000 | 5.5% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $4.6M | 210,000 | 5.4% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $3.4M | 118,344 | 3.9% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $512.0K | 135,000 | 0.6% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $15.4K | 325,000 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $12.9K | 350,000 | 0.0% |
| Merus N V | COM | N5749R100 | $11.1K | 350,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $10.5K | 625,000 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $9.9K | 500,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA)Call | COM | 462260100 | $9.5K | 500,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $9.3K | 425,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $9.0K | 100,000 | 0.0% |
| Bellus Health Inc New(BLU)Put | COM NEW | 07987C204 | $7.2K | 891,000 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $6.7K | 80,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $6.6K | 300,000 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $5.9K | 250,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $5.8K | 500,000 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $5.4K | 250,000 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $5.0K | 750,000 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $4.5K | 200,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $4.4K | 30,000 | 0.0% |
| Leap Therapeutics Inc | COM | 52187K101 | $4.4K | 1,350,000 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $4.2K | 250,000 | 0.0% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $4.1K | 904,225 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $3.9K | 2,000,000 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $3.8K | 170,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $3.6K | 450,000 | 0.0% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $3.2K | 295,000 | 0.0% |
| 9 Meters Biopharma Inc | COM | 654405109 | $3.2K | 3,250,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $3.2K | 225,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.1K | 100,000 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $3.0K | 1,200,000 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $2.9K | 135,000 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $2.4K | 225,000 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $2.3K | 100,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $1.8K | 60,000 | 0.0% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $1.6K | 165,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $1.5K | 55,000 | 0.0% |
| Aldeyra Therapeutics Inc(ALDX)Call | COM | 01438T106 | $1.2K | 300,000 | 0.0% |
| Pardes Biosciences Inc | COM | 69945Q105 | $819 | 50,000 | 0.0% |